Bruce Birmingham Fund – Providing hope for transplant patients

Bruce Birmingham was a respected businessman, colleague and friend. Before
retiring in 2002, he was instrumental to the international expansion of Scotiabank during his distinguished 30-year career. Beyond the business world, Bruce was a dedicated family man and passionate about supporting causes that made life better for all Canadians.

In 2010, shortly after a successful liver transplant at Toronto General Hospital, Bruce lost his courageous battle with his illness. He is tremendously missed by family, friends and colleagues alike.

Through a leadership gift of $1 million from the Birmingham family, together with almost $100,000 contributed by Scotiabank employees to date, the Bruce Birmingham Tribute Fund honours Bruce's strong belief that the greatest donation is the gift of life. Fundraising efforts continue, with the goal of naming the Bruce Birmingham Transplant In-Patient Unit within UHN's Multi-Organ Transplant Program. The Centre will serve as a state-of-the-art facility for our transplant surgeons and researchers, and a recuperative space for patients and their families.

Founded in 1991, UHN's Multi-Organ Transplant Program has grown to become the largest program in Canada and the sixth largest in North America.

Currently, the program saves the lives of nearly 400 individuals every year and provides ongoing care to over 3,000 transplant recipients. It is anticipated that transplantation needs will double and potentially triple in the next five years. The program treats the most complex and highest acuity transplant patients, and our high standard of care rivals any other program of its kind in the world.

"Bruce would be proud of having his name attached to such an important cause," said Betty Birmingham, Bruce's widow. "Bruce was as driven about his philanthropy as he was about his work. He had a warm heart, and a great generosity towards doing what he could to make people's lives better."

Funds derived from the Tribute will help drive the clinical, research and educational ambitions of the Multi-Organ Transplant Program, improving long-term outcomes for patients.